Abstract
Background: New highly sensitive (hs) assays have challenged the interpretation of cardiac troponins (cTn). The present study was designed to evaluate simultaneously conventional cTnT and cTnI together with their corresponding highly sensitive determinations in stable hemodialysis (HD) patients. Ability of cTn to stratify HD patient risk was assessed.
Methods: A total of 224 stable HD patients was included in this observational study. cTnT and hs-cTnT were measured using Roche cTnT/hs-cTnT assays based on a Cobas e601® analyzer. cTnI and hs-cTnI were measured using Beckman AccuTnI/hs-TnI IUO assays on Access II system. Patients were followed up prospectively during 9 years. Relationship between cTn level and mortality was assessed through Cox survival analysis.
Results: The median cTnT and cTnI concentrations were 38.5 ng/L (IQR, 18.8–76) and 10 ng/L (IQR, 10–20), respectively. The median hs-cTnT and hs-cTnI concentrations were 62.5 ng/L (IQR, 38.8–96.3) and 13.9 ng/L (IQR, 8.4–23.6), respectively. The prevalence of values above the 99th percentile was significantly more marked with cTnT (85.3 and 97.8% for conventional and hs cTnT, respectively) than with cTnI (7.6 and 67.4% for conventional and hs cTnI, respectively). During the follow-up, 167 patients died, mainly from cardiac cause (n=77). The optimized cut-off values, determined by bootstrap method, predicting mortality were 38, 69, 20 and 11 ng/L for cTnT, hs-cTnT, cTnI and hs-cTnI, respectively. After full adjustment, elevated plasma concentrations of all troponin were significant predictors of mortality.
Conclusions: A large proportion of patients free of acute coronary syndrome (ACS) has hs-cTn I or T higher than the 99th percentile which could be seen as a limiting factor for ACS screening. However, all generation and type of troponin assays could be reliable indicators of prognosis risk in HD patients.
References
1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112–9.10.1053/ajkd.1998.v32.pm9820470Search in Google Scholar
2. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353–62.10.1046/j.1523-1755.2000.00173.xSearch in Google Scholar
3. Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 2001;38:991–8.10.1016/S0735-1097(01)01513-3Search in Google Scholar
4. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941–5.10.1161/01.CIR.0000041254.30637.34Search in Google Scholar PubMed
5. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. J Am Med Assoc 2003;290:353–9.10.1001/jama.290.3.353Search in Google Scholar PubMed
6. Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol 2008;19:1643–52.10.1681/ASN.2008010012Search in Google Scholar PubMed
7. Boulier A, Jaussent I, Terrier N, Maurice F, Rivory JP, Chalabi L, et al. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients. Nephrol Dial Transplant 2004;19:2313–8.10.1093/ndt/gfh365Search in Google Scholar PubMed
8. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088–96.10.1161/CIRCULATIONAHA.105.560128Search in Google Scholar PubMed
9. Brunet P, Oddoze C, Paganelli F, Indreies M, Faure V, Opris-Saveanu A, et al. Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome. Int J Cardiol 2008;129:205–9.10.1016/j.ijcard.2007.07.004Search in Google Scholar PubMed
10. Hickman PE, Koerbin G, Southcott E, Tate J, Dimeski G, Carter A, et al. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Ann Clin Biochem 2007;44:285–9.10.1258/000456307780480855Search in Google Scholar PubMed
11. Deléaval P, Descombes E, Magnin JL, Martin PY, Fellay G. Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays. Nephrol Ther 2006;2:75–81.10.1016/j.nephro.2005.11.003Search in Google Scholar
12. End C, Seliger SL, deFilippi CR. Interpreting cardiac troponin results from highly sensitive assays in patients with chronic kidney disease: acute coronary syndromes and beyond. Coron Artery Dis 2013;24:720–3.10.1097/MCA.0000000000000046Search in Google Scholar
13. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995;2:295–304.10.1016/S1073-4449(12)80028-8Search in Google Scholar
14. Kavsak PA, Xu L, Yusuf S, McQueen MJ. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011;57:1146–53.10.1373/clinchem.2011.164574Search in Google Scholar PubMed
15. Apple FS, Jaffe AS. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin Chem 2012;58:1599–600.10.1373/clinchem.2012.194985Search in Google Scholar PubMed
16. Kuster N, Dupuy AM, Monnier K, Baptista G, Bargnoux AS, Badiou S, et al. Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin Chem 2013;59:570–2.10.1373/clinchem.2012.197020Search in Google Scholar PubMed
17. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008;29:S49–52.Search in Google Scholar
18. Hung H, Chiang C. Estimation methods for time-dependent AUC with survival data. Can J Stat 2010;38:8–26Search in Google Scholar
19. Uno H, Tian L, Cai T, Kohane IS, Wei LJ. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med 2013;32:243024–42.10.1002/sim.5647Search in Google Scholar PubMed PubMed Central
20. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574–81.10.1373/clinchem.2012.192716Search in Google Scholar PubMed
21. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254–61.10.1373/clinchem.2009.132654Search in Google Scholar PubMed
22. Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem 2009;55:1303–6.10.1373/clinchem.2009.128363Search in Google Scholar PubMed
23. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086–90.10.1373/clinchem.2009.140616Search in Google Scholar
24. Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009;55:1809–15.10.1373/clinchem.2009.127241Search in Google Scholar
25. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:1165–72.10.1016/j.jacc.2009.05.051Search in Google Scholar
26. Artunc F, Mueller C, Breidthardt T, Twerenbold R, Peter A, Thamer C, et al. Sensitive troponins – which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One 2012;7:e47610.10.1371/journal.pone.0047610Search in Google Scholar
27. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002;40:2065–71.10.1016/S0735-1097(02)02608-6Search in Google Scholar
28. Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004;109:23–5.10.1161/01.CIR.0000109483.45211.8FSearch in Google Scholar PubMed
29. Gaze DC, Collinson PO. Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis. Open Heart 2014;1:e000108.10.1136/openhrt-2014-000108Search in Google Scholar PubMed PubMed Central
30. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551–67.10.1093/eurheartj/ehs184Search in Google Scholar PubMed
31. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219–25.10.1373/clinchem.2011.171082Search in Google Scholar PubMed
32. Kuster N, Monnier K, Baptista G, Dupuy AM, Badiou S, Bargnoux AS, et al. Estimation of age- and comorbidities-adjusted percentiles of high-sensitivity cardiac troponin T levels in the elderly. Clin Chem Lab Med 2015;53:691–8.10.1515/cclm-2014-0121Search in Google Scholar PubMed
33. Clementi A, Virzì GM, Goh CY, Cruz DN, Granata A, Vescovo G, et al. Cardiorenal syndrome type 4: a review. Cardiorenal Med 2013;3:63–70.10.1159/000350397Search in Google Scholar PubMed PubMed Central
34. Pfortmueller CA, Funk GC, Marti G, Leichtle AB, Fiedler GM, Schwarz C, et al. Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. Am J Cardiol 2013;112:1968–72.10.1016/j.amjcard.2013.08.028Search in Google Scholar PubMed
35. Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, et al. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J 2009;39:812–8.10.1111/j.1445-5994.2009.01846.xSearch in Google Scholar PubMed
36. Michos ED, Wilson LM, Yeh HC, Berger Z, Suarez-Cuervo C, Stacy SR, et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review. Ann Intern Med 2014;161: 491–501.10.7326/M14-0743Search in Google Scholar PubMed
37. Bargnoux AS, Morena M, Jaussent I, Maurice F, Chalabi L, Leray-Moragues H, et al. A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysispatients. Clin Chem Lab Med 2013;51:1865–74.10.1515/cclm-2012-0664Search in Google Scholar PubMed
38. McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010;411:936–9.10.1016/j.cca.2010.03.004Search in Google Scholar PubMed
39. Hassan HC, Howlin K, Jefferys A, Spicer ST, Aravindan AN, Suryanarayanan G, et al. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clin Chem 2014;60:389–98.10.1373/clinchem.2013.207142Search in Google Scholar PubMed
40. Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney Int 2002;62:1884–90.10.1046/j.1523-1755.2002.00641.xSearch in Google Scholar PubMed
41. Basit M, Bakshi N, Hashem M, Allebban Z, Lawson N, Rosman HS, et al. The effect of freezing and long-term storage on the stability of cardiac troponin T. Am J Clin Pathol 2007;128:164–7.10.1309/LR7FC0LUGLHT8X6JSearch in Google Scholar PubMed
42. Aakre KM, Røraas T, Petersen PH, Svarstad E, Sellevoll H, Skadberg Ø, et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin Chem 2014;60:838–47.10.1373/clinchem.2013.216978Search in Google Scholar PubMed
43. Chazot C, Vo-Van C, Zaoui E, Vanel T, Hurot JM, Lorriaux C, et al. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrol Dial Transplant 2011;26:2630–4.10.1093/ndt/gfq804Search in Google Scholar PubMed
©2016 by De Gruyter
